Cardiovascular complications of immunosuppressive agents in renal transplant recipients

Ali J. Olyaei, Angelo M DeMattos, William M. Bennett

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Fatal and nonfatal cardiovascular events are the most important cause of graft loss in patients with a functioning graft following transplantation. The available data indicate that transplant patients have a high prevalence of hypertension, hyperlipidaemia and new onset diabetes mellitus after transplantation. The aetiology and pathogenesis of post-transplant hypertension, hyperlipidaemia and diabetes are multifactorial. In addition, disease of the native kidney and recurrence of renal disease can contribute to the development of cardiovascular disease in transplant recipients. Most transplant patients are at risk of clinically important drug-drug interactions involving immunosuppressive agents. Adverse reactions and drug-drug interactions should not be neglected when selecting an agent for treatment of cardiovascular risk factors in transplant recipients.

Original languageEnglish (US)
Pages (from-to)29-44
Number of pages16
JournalExpert Opinion on Drug Safety
Volume4
Issue number1
DOIs
StatePublished - Jan 2005
Externally publishedYes

Fingerprint

Immunosuppressive Agents
Transplants
Kidney
Hyperlipidemias
Drug Interactions
Transplantation
Hypertension
Cardiovascular Agents
Kidney Diseases
Drug-Related Side Effects and Adverse Reactions
Diabetes Mellitus
Cardiovascular Diseases
Transplant Recipients
Recurrence
Pharmaceutical Preparations
Therapeutics

Keywords

  • Cardiovascular complications
  • Diabetes
  • Hyperlipidaemia
  • Hypertension
  • Immunosuppressive
  • Renal transplant

ASJC Scopus subject areas

  • Pharmacology

Cite this

Cardiovascular complications of immunosuppressive agents in renal transplant recipients. / Olyaei, Ali J.; DeMattos, Angelo M; Bennett, William M.

In: Expert Opinion on Drug Safety, Vol. 4, No. 1, 01.2005, p. 29-44.

Research output: Contribution to journalArticle

@article{97144061afb440499305852787f57365,
title = "Cardiovascular complications of immunosuppressive agents in renal transplant recipients",
abstract = "Fatal and nonfatal cardiovascular events are the most important cause of graft loss in patients with a functioning graft following transplantation. The available data indicate that transplant patients have a high prevalence of hypertension, hyperlipidaemia and new onset diabetes mellitus after transplantation. The aetiology and pathogenesis of post-transplant hypertension, hyperlipidaemia and diabetes are multifactorial. In addition, disease of the native kidney and recurrence of renal disease can contribute to the development of cardiovascular disease in transplant recipients. Most transplant patients are at risk of clinically important drug-drug interactions involving immunosuppressive agents. Adverse reactions and drug-drug interactions should not be neglected when selecting an agent for treatment of cardiovascular risk factors in transplant recipients.",
keywords = "Cardiovascular complications, Diabetes, Hyperlipidaemia, Hypertension, Immunosuppressive, Renal transplant",
author = "Olyaei, {Ali J.} and DeMattos, {Angelo M} and Bennett, {William M.}",
year = "2005",
month = "1",
doi = "10.1517/14740338.4.1.29",
language = "English (US)",
volume = "4",
pages = "29--44",
journal = "Expert Opinion on Drug Safety",
issn = "1474-0338",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Cardiovascular complications of immunosuppressive agents in renal transplant recipients

AU - Olyaei, Ali J.

AU - DeMattos, Angelo M

AU - Bennett, William M.

PY - 2005/1

Y1 - 2005/1

N2 - Fatal and nonfatal cardiovascular events are the most important cause of graft loss in patients with a functioning graft following transplantation. The available data indicate that transplant patients have a high prevalence of hypertension, hyperlipidaemia and new onset diabetes mellitus after transplantation. The aetiology and pathogenesis of post-transplant hypertension, hyperlipidaemia and diabetes are multifactorial. In addition, disease of the native kidney and recurrence of renal disease can contribute to the development of cardiovascular disease in transplant recipients. Most transplant patients are at risk of clinically important drug-drug interactions involving immunosuppressive agents. Adverse reactions and drug-drug interactions should not be neglected when selecting an agent for treatment of cardiovascular risk factors in transplant recipients.

AB - Fatal and nonfatal cardiovascular events are the most important cause of graft loss in patients with a functioning graft following transplantation. The available data indicate that transplant patients have a high prevalence of hypertension, hyperlipidaemia and new onset diabetes mellitus after transplantation. The aetiology and pathogenesis of post-transplant hypertension, hyperlipidaemia and diabetes are multifactorial. In addition, disease of the native kidney and recurrence of renal disease can contribute to the development of cardiovascular disease in transplant recipients. Most transplant patients are at risk of clinically important drug-drug interactions involving immunosuppressive agents. Adverse reactions and drug-drug interactions should not be neglected when selecting an agent for treatment of cardiovascular risk factors in transplant recipients.

KW - Cardiovascular complications

KW - Diabetes

KW - Hyperlipidaemia

KW - Hypertension

KW - Immunosuppressive

KW - Renal transplant

UR - http://www.scopus.com/inward/record.url?scp=12544260035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12544260035&partnerID=8YFLogxK

U2 - 10.1517/14740338.4.1.29

DO - 10.1517/14740338.4.1.29

M3 - Article

VL - 4

SP - 29

EP - 44

JO - Expert Opinion on Drug Safety

JF - Expert Opinion on Drug Safety

SN - 1474-0338

IS - 1

ER -